Nachrichten zur Hims & Hers Health Aktie

…

Hims & Hers saw a massive YTD surge, but FDA news led to a pullback. Find out why HIMS stock…

We recently compiled a list of the Wall Street Optimism Spills Over to These 10 Stocks on Friday. In this article,…

We recently compiled a list of the Wall Street Optimism Spills Over to These 10 Stocks on Friday. In this…

Although the telemedicine company displayed blistering growth and issued robust guidance, shares of Hims & Hers (NYSE: HIMS) plummeted following…

Although the telemedicine company displayed blistering growth and issued robust guidance, shares of Hims & Hers (NYSE: HIMS) plummeted following…

QRG Capital Management Inc. boosted its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report)…

Hims & Hers Health (NYSE:HIMS) Shares Up 4.9% - Whats Next?…

Shares of Hims & Hers Health (NYSE: HIMS) sank 10.5% this week, according to data from S&P Global Market Intelligence.…

Hims & Hers Health (HIMS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise…

Plus, Modernas bird flu contract with the U.S. is being evaluated…

Eli Lilly announced plans to invest $27 billion in four new manufacturing sites in the United States. The pharma giant…

We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on Substack by Antonio Linares. In this article, we…

New York (www.aktiencheck.de) - Hims & Hers Health-Aktienanalyse von TD Cowen: Rating und Kursziel TD Cowen hat das Kursziel für die Aktie…

Hims and Hers shows strong profitability and subscriber growth. Find out why HIMS stock has a fair value of $80,…

Hims & Hers stock drops 26% as FDA resolves semaglutide shortage, threatening GLP-1 revenue. Click here to find out why…

Hims and Hers Health produced sterling results on Feb. 24, spurring huge interest in HIMS call options trading. Barchart reported…

We recently published an article titled Two of 10 Worst-Performing Stocks Fall to All-Time Lows on Tuesday. In this article,…

Hims & Hers Health targets the $4T U.S. healthcare industry, boasting 95% y/y revenue growth. Click here to find out…

Hims & Hers Health ( ($HIMS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual…

Hims & Hers Health, Inc. (($HIMS)) has held its Q4 earnings call. Read on for the main highlights of the…

We recently published a list of Jim Cramer on 10 Stocks With The Biggest Declines Last Week. In this article,…

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Michael Chi sold 17,303 shares of the businesss stock…